Clinical Trial Update: A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA). [Phase 2, Phase 3]

View source ↗

Summary

A safety and effectiveness study evaluating intravenous anidulafungin in combination with AmBisome for invasive aspergillosis (Phase 2/Phase 3; status completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)
• Eraxis (Anidulafungin) (Anidulafungin)

Snippet

Sponsor: Pfizer | Conditions: Aspergillosis | Phase 2, Phase 3 | Status: COMPLETED